12
●
急性リンパ性白血病 ALL
5) Smith M, Arthur D, Camitta B, et al. Uniform approach to risk classification and treatment as-
signment for children with acute lymphoblastic leukemia. J Clin Oncol 1996 ; 14 : 18-24.
6) Pui CH, Howard SC. Current management and challenges of malignant disease in the CNS in
paediatric leukaemia. Lancet Oncol 2008 ; 9 : 257-68.
7) Nachman JB, Heerema NA, Sather H, et al. Outcome of treatment in children with hypodiploid
acute lymphoblastic leukemia. Blood 2007 ; 110 : 1112-5.
8) Pui CH, Gaynon PS, Boyett JM, et al. Outcome of treatment in childhood acute lymphoblastic leu-
kaemia wuth rearrangement of the 11q23 chromosomal region. Lancet 2002 ; 359 : 1909-15.
9) Inukai T, Hirose K, Inaba T, et al. Hypercalcemia in childhood acute lymphoblastic leukemia :
frequent implication of parathyroid hormone-related peptide and E2A-HLF from translocation
17;19. Leukemia 2007 ; 21 : 288-96.
10) Möricke A, Reiter A, Zimmermann M, et al. Risk-adjusted therapy of acute lymphoblastic leuke-
mia can decrease treatment burden and improve survival : treatment results of 2169 unselected
pediatric and adlescent patients enrolled in the trial ALL-BFM95. Blood 2008 ; 111 : 4477-89.
11) Seibel NL, Steinherz PG, Sather HN, et al. Early postinduction intensification therapy improves
survival for children and adolescents with high-risk acute lymphoblastic leukemia : a report
from the Children’s Oncology Group. Blood 2008 ; 111 : 2548-55.
12) Schrappe M, Hunger SP, Pui CH, et al. Outcomes after induction failure in childhood acute lym-
phoblastic leukemia. N Engl J Med 2012 ; 366 : 1371-81.
13) van Dongen JJ, Seriu T, Panzer-Grumayer ER, et al. Prognostic value of minimal residual disease
in acute lymphoblastic leukaemia in childhood. Lancet 1998 ; 352 : 1731-8.
14) Coustan-Smith E, Behm FG, Sanchez J, et al. Immunological detection of minimal residual dis-
ease in children with acute lymphoblastic leukaemia. Lancet 1998 ; 351 : 550-4.